Rating History for Silence Therapeutics (SLN) by William Blair

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/19/2026 Myles Minter Downgrade Market Perform
(Outperform)
N/A
(N/A)
8.68
(19.67)
126.61% Details